Patents Examined by Todd M Epstein
  • Patent number: 11746353
    Abstract: A Saccharomyces cerevisiae strain with high yield of ethyl butyrate and a construction method and an application thereof are provided. The strain is obtained by over-expressing in the starting strain acetyl coenzyme A acyl transferase gene Erg10, 3-hydroxybutyryl coenzyme A dehydrogenase gene Hbd, 3-hydroxybutyryl coenzyme A dehydratase gene Crt, trans-2-enoyl coenzyme A reductase gene Ter, and alcohol acyl transferase gene AAT. Compared to the starting bacteria not producing ethyl butyrate, the yield of ethyl butyrate of the constructed strain reaches 77.33±3.79 mg/L, the yield of the ethyl butyrate of the strain with double copy expression of gene Ter and gene AAT reaches 99.65±7.32 mg/L, increased by 28.9% compared with the EST strain, and 40.93±3.18 mg/L of ethyl crotonate is unexpectedly produced.
    Type: Grant
    Filed: December 25, 2020
    Date of Patent: September 5, 2023
    Assignee: Tianjin University of Science and Technology
    Inventors: Yefu Chen, Yanrui Ma, Yongjing Du, Sen Jiang, Jinying Ren, Guo Zhang, Xinyue Kang, Peng Zheng, Xiaole Wu, Dongguang Xiao, Xuewu Guo
  • Patent number: 11744263
    Abstract: The present invention relates to animal feed or animal feed additives comprising polypeptides having protease activity and uses thereof. It also relates to the methods for producing the proteases and for using the proteases to improve animal performance and the nutritional value of an animal feed.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: September 5, 2023
    Assignee: Novozymes A/S
    Inventors: Laerke Tvedebrink Haahr, Tine Hoff, Peter Rahbek Oestergaard
  • Patent number: 11739310
    Abstract: An amino acid sequence may have at least 70% sequence identity to the amino acid sequence identified in SEQ ID No. 1 over its entire length, and (a) an amino acid substitution on the position corresponding to the position 271, and (b1) at least one other amino acid substitution for at least one of the positions corresponding to the positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217, 265, or combinations thereof; and/or (b2) an amino acid substitution on the position corresponding to the position 9, and another amino acid substitution for at least one position corresponding to the positions 29, 48, 101, 130, 31, 133, 144, 217, 224, 252, or combinations thereof. Such proteases are useful for in washing or cleaning agents.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: August 29, 2023
    Assignee: Henkel AG & Co. KGaA
    Inventors: Nina Mussmann, Susanne Wieland, Daniela Herbst, Inken Prueser, Christian Degering, Daria Strauss, Thorsten Eggert, Christian Leggewie, Layla Fernandez, Sabine Griemert
  • Patent number: 11680256
    Abstract: A bacterial strain comprising one or more vectors encoding a) one or more enzymes to produce one or more terpene precursors; and b) a fungal terpene synthase (FTPS). The present invention also relates to a method of producing a terpenoid comprising a) culturing the bacterial strain described herein in an expression medium; and b) isolating the terpenoid from said expression medium.
    Type: Grant
    Filed: September 2, 2019
    Date of Patent: June 20, 2023
    Assignees: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH, JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
    Inventors: Congqiang Zhang, Xixian Chen, Ruehl Martin, Heng-Phon Too
  • Patent number: 11661587
    Abstract: Disclosed are luciferase polypeptides with improved light-emitting activity and their encoding nucleic acids. These molecules are useful in a range of assays including luciferase-based gene reporter assays, bioluminescence resonance energy transfer assays, protein complementation assays and other applications in which luciferase enzymes are utilized as detectable and/or quantifiable labels. Also disclosed are methods and compositions for increasing the sensitivity and/or improving the kinetics of luciferase-catalyzed reactions as well as decreasing the impact of undesirable variables.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: May 30, 2023
    Assignee: Promega Corporation
    Inventors: John Michael Daly, Leon Michael Brownrigg, Jim Yu-Hsiang Tiao
  • Patent number: 11655464
    Abstract: An alkaline protease mutant, and a gene, engineered strain, a preparation method and application thereof are provided. The method comprises the following steps of extracting genome DNA of Bacillus clausii, performing PCR amplification to obtain a wild-type alkaline protease gene sequence, mutating the wild-type alkaline protease gene obtained by the amplification through an error-prone PCR, performing high-throughput screening to obtain a plurality of highly active alkaline protease genes, performing DNA shuffling on the highly active alkaline protease genes, and performing screening to obtain eight alkaline protease mutant genes with higher activity.
    Type: Grant
    Filed: July 31, 2022
    Date of Patent: May 23, 2023
    Assignees: Tianjin University of Science and Technology, Shandong Lonct Enzymes Co. LTD
    Inventors: Fuping Lu, Yihan Liu, Yu Li, Xingji Wang, Kefen Wang, Wenlong Liu, Fufeng Liu, Huitu Zhang
  • Patent number: 11643663
    Abstract: The invention relates to the ADH3 promoter; polynucleotide sequences, vectors and expression cassettes including DNA regions responsible for the regulation of the ADH3 promoter; the host cells, including these vectors and expression cassettes, and, the recombinant proteins performed with the developed cells. In the scope of the invention, deletion analyzes in the ADH3 promoter were performed to identify regions that affect promoter strength and significant data was obtained in the formation of mutant ADH3 promoters. Deletion of the nucleotides between 539 and 638 (?361 to ?262) in SEQ ID NO: 1 resulted in a 63% increase in ADH3 promoter activity. Five different synthetic promoters were created using positive regulatory regions identified and approximately 165% to 200% promoter activities were achieved with these promoters.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: May 9, 2023
    Assignee: AKDENIZ UNIVERSITESI
    Inventors: Mehmet Inan, Mert Karaoglan, Fidan Erden Karaoglan
  • Patent number: 11643675
    Abstract: The invention provides compositions and methods for engineering E. coli or other host production bacterial strains to produce fucosylated oligosaccharides, and the use thereof in the prevention or treatment of infection.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: May 9, 2023
    Assignee: Glycosyn LLC
    Inventors: John M. McCoy, Matthew Ian Heidtman, Massimo Merighi
  • Patent number: 11634701
    Abstract: The present invention relates to the conversion of a carbon source into acetyl phosphate with increased carbon yield. In particular, the invention provides metabolically engineered micro-organisms capable of producing acetyl phosphate from a carbon source with increased carbon yield, which micro-organisms have been transformed with at least one exogenous nucleic acid encoding a phosphoketolase having sedoheptulose-7-phosphate phosphoketolase activity and which are further genetically modified to have eliminated transketolase activity. The invention also provides methods for the production of chemicals using said micro-organisms.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: April 25, 2023
    Assignee: TOTAL RAFFINAGE CHIMIE
    Inventor: Alexei Godina
  • Patent number: 11618908
    Abstract: The present disclosure provides methods and compositions for producing rotundone. In various aspects, the present disclosure provides enzymes, polynucleotides encoding said enzymes, and recombinant microbial host cells (or microbial host strains) for the production of rotundone. In some embodiments, the present disclosure provides microbial host cells for producing rotundone at high purity and/or yield, from either enzymatic transformation of ?-guaiene, or from sugar or other carbon source. The present disclosure further provides methods of making products containing rotundone, including flavor or fragrance products, among others.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: April 4, 2023
    Assignee: MANUS BIO INC.
    Inventors: Ryan N. Philippe, Ajikumar Parayil Kumaran, Christine Nicole S. Santos, Jason Donald, Stephen Sarria
  • Patent number: 11618890
    Abstract: Provided are non-natural or variant beta-ketoacyl-acyl carrier protein (ACP) synthase (KAS) II enzymes (KASII), polynucleotides encoding such variant KASII, host cells expressing such variant KASII, oils and oil products produced by such cells, and methods of making and using such variant KASII.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: April 4, 2023
    Assignee: Corbion Biotech, Inc.
    Inventors: Nien-Hsi Ko, Joshua Ferreira, Janice Lau Wee, William E. Maffe, Douglas A. Hattendorf
  • Patent number: 11597918
    Abstract: The present disclosure relates to transaminase polypeptides capable of aminating a dicarbonyl substrate, and polynucleotides, vectors, host cells, and methods of making and using the transaminase polypeptides.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: March 7, 2023
    Assignee: Codexis, Inc.
    Inventors: Fabien Louis Cabirol, Haibin Chen, Anupam Gohel, Paulina Elena Salim, Derek J. Smith, Jacob Janey, Birgit Kosjek, Weng Lin Tang, Helen Hsieh, Son Q. Pham
  • Patent number: 11572546
    Abstract: The current methods and compositions provide for nucleotide sequences of promoters from Yarrowia lipolytica which may be used to drive gene expression in a cell. In some aspects, the promoters are useful for modulating lipid production in oleaginous organisms such as yeast.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: February 7, 2023
    Assignee: GINKGO BIOWORKS, INC.
    Inventors: Vasiliki Tsakraklides, Annapurna Kamineni
  • Patent number: 11566269
    Abstract: The present disclosure provides recombinant microorganisms and methods for the production of 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA from a carbon source. The method provides for engineered microorganisms that express endogenous and/or exogenous nucleic acid molecules that catalyze the conversion of a carbon source into 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA. The disclosure further provides methods of producing polymers derived from 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: January 31, 2023
    Assignee: BRASKEM S.A.
    Inventors: Paulo Moises Raduan Alexandrino, Iuri Estrada Gouvea, Veronica Leite Queiroz, Marcos Rogerio Simões
  • Patent number: 11566270
    Abstract: The present disclosure provides recombinant microorganisms and methods for the production of 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA from a carbon source. The method provides for engineered microorganisms that express endogenous and/or exogenous nucleic acid molecules that catalyze the conversion of a carbon source into 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA. The disclosure further provides methods of producing polymers derived from 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: January 31, 2023
    Assignee: BRASKEM S.A.
    Inventors: Paulo Moises Raduan Alexandrino, Iuri Estrada Gouvea, Veronica Leite Queiroz, Felipe Cicaroni Fernandes, Bárbara Mano
  • Patent number: 11560576
    Abstract: The present disclosure relates to genetically engineered host cells and methods of producing a lipid-derived compound by employing such host cells. In particular embodiments, the host cell includes a first mutant gene encoding a cytoplasmic tRNA thiolation protein. Optionally, the host cell can include other mutant genes for decreasing fatty alcohol catabolism, decreasing re-importation of secreted fatty alcohol, or displaying other useful characteristics, as described herein.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: January 24, 2023
    Assignee: National Technology & Engineering Solutions of Sandia, LLC
    Inventors: Samuel Coradetti, John Michael Gladden, Di Liu, Gina Marie Geiselman
  • Patent number: 11555194
    Abstract: Isolated nucleic acids, expression methods, host cells, expression vectors, and DNA constructs for producing proteins, and proteins produced using the expression methods are disclosed. More specifically, nucleic acids isolated from Pichia pastons having promoter activity and expression methods, host cells, expression vectors, and DNA constructs of using the Pichia pastons promoters to produce different proteins and polypeptides are disclosed.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: January 17, 2023
    Assignee: BIOGRAMMATICS, INC.
    Inventors: Ilya I. Tolstorukov, James M. Cregg, Thomas G. Chappell, Knut R. Madden
  • Patent number: 11542479
    Abstract: The invention discloses an alcohol dehydrogenase mutant and use thereof. The alcohol dehydrogenase mutant of the present invention has high thermal stability and enables high catalytic efficiency and high conversion rate (i.e. space time yield) in the asymmetric reduction of prochiral diaryl ketones to produce chiral diaryl alcohols. Therefore, the alcohol dehydrogenase mutant of the present invention has extremely high prospect of application in the production of chiral diaryl alcohols, such as (S)-(4-chlorophenyl)-(pyridin-2-yl)-methanol, (R)-(4-chlorophenyl)-(pyridin-2-yl)-methanol.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: January 3, 2023
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Ye Ni, Wei Dai, Guochao Xu, Jieyu Zhou, Ruizhi Han, Jinjun Dong
  • Patent number: 11535877
    Abstract: The present invention relates generally to the field of industrial biotechnology and particularly to an improved hydrolysis method for increasing sugar production from a high solids concentration of lignocellulosic biomass, especially one derived from Municipal Solid Waste (MSW) by enzymatic hydrolysis of a lignocellulosic biomass to obtain a slurry, wherein the hydrolysis comprises aliquot additions of enzyme and lignocellulosic biomass; and removal of sugars from the slurry and washing of the residual lignocellulosic biomass.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: December 27, 2022
    Assignee: FIBERIGHT LIMITED
    Inventors: Nicholas Mark Thompson, Dhivya Jyoti Puri, Peter Speller
  • Patent number: 11535876
    Abstract: The present disclosure relates to the field of genetic engineering, especially relates to a xylose-induced genetically engineered bacteria used for producing ectoine as well as a construction method and use thereof. The genetically engineered bacteria is constructed by heterologously expressing the ectABC gene cluster from Halomonas elongata on the E. coli chromosome, using the promoter of xylose transporter coding gene xylF to control the RNA polymerase from T7 bacteriophage, reconstructing a synthesis pathway of ectoine and constructing a plasmid-free system, and enhancing the expression of target genes by a strong promoter T7; the yield of ectoine reached 12-16 g/L after 20-28 h fermentation in shake flask, and reached 35-50 g/L after 24-40 h fermentation in a 5 L fermentor.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: December 27, 2022
    Assignee: Tianjin University of Science and Technology
    Inventors: Xixian Xie, Xuejiao Wu, Ning Chen, Fangqing Yan, Qian Ma, Jie Ma, Hongchao Zhang